Drugs Made In America Acquisition II Units
DMIIU10.160USD
0.0000.00%
交易中 （美东）报价延迟15分钟
666.24M总市值
--市盈率 TTM
关于 公司
Drugs Made In America Acquisition II Units简介
公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -
Drugs Made In America Acquisition II Units公司高管
名称
名称/职务
职务
持股
持股变动
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
名称
名称/职务
职务
持股
持股变动
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 12月10日 周三
更新时间: 12月10日 周三
持股股东
股东类型
持股股东
持股股东
占比
Magnetar Capital Partners LP
4.12%
MMCAP Asset Management
4.12%
Glazer Capital, LLC
3.58%
LMR Partners LLP
3.05%
Millennium Management LLC
3.05%
其他
82.08%
持股股东
持股股东
占比
Magnetar Capital Partners LP
4.12%
MMCAP Asset Management
4.12%
Glazer Capital, LLC
3.58%
LMR Partners LLP
3.05%
Millennium Management LLC
3.05%
其他
82.08%
股东类型
持股股东
占比
Hedge Fund
39.46%
Investment Advisor/Hedge Fund
16.55%
Investment Advisor
7.62%
Pension Fund
5.18%
Research Firm
1.42%
Corporation
1.07%
Bank and Trust
0.20%
其他
28.49%
机构持股
更新时间: 12月9日 周二
更新时间: 12月9日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q4
78
46.21M
0.02%
--
2025Q3
76
45.95M
70.07%
+45.95M
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Magnetar Capital Partners LP
2.70M
4.12%
+2.70M
--
Sep 30, 2025
MMCAP Asset Management
2.70M
4.12%
+2.70M
--
Sep 30, 2025
Glazer Capital, LLC
2.35M
3.58%
+2.35M
--
Sep 30, 2025
LMR Partners LLP
2.00M
3.05%
+2.00M
--
Sep 30, 2025
Millennium Management LLC
2.00M
3.05%
+2.00M
--
Sep 30, 2025
Healthcare Of Ontario Pension Plan
2.00M
3.05%
+2.00M
--
Sep 30, 2025
Hudson Bay Capital Management LP
1.97M
3%
+1.97M
--
Sep 30, 2025
First Trust Capital Management L.P.
1.88M
2.87%
+1.88M
--
Sep 30, 2025
Tenor Capital Management Co., L.P.
1.50M
2.29%
+1.50M
--
Sep 30, 2025
Polar Asset Management Partners Inc.
1.50M
2.29%
+1.50M
--
Sep 30, 2025
查看更多
持股ETF
更新时间: 12月9日 周二
更新时间: 12月9日 周二
机构名称
占比
SPAC and New Issue ETF
0%
SPAC and New Issue ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
